2021
DOI: 10.1002/jcp.30353
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of connexin43 potentiates noradrenaline‐induced expression of brain‐derived neurotrophic factor in primary cultured cortical astrocytes

Abstract: Decreased expression of brain‐derived neurotrophic factor (BDNF) is involved in the pathology of depressive disorders. Astrocytes produce BDNF following antidepressant treatment or stimulation of adrenergic receptors. Connexin43 (Cx43) is mainly expressed in central nervous system astrocytes and its expression is downregulated in patients with major depression. How changes in Cx43 expression affect astrocyte function, including BDNF production, is poorly understood. The current study examined the effect of Cx4… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…While the involvement of noradrenergic signaling was not tested in this study (Martínez-Gallego et al, 2022), it clearly adds to the evidence that astrocytes are potent helmsmen of synaptic plasticity direction (Falcón-Moya et al, 2020;Hennes et al, 2020;Wahis et al, 2021b;Koh et al, 2022). Future studies could also explore the molecular mechanisms underlying the role of astrocytes in NA-mediated plasticity in V1, for instance by testing the involvement of potential gliotransmitters, such as ATP/Adenosine, D-Serine, GABA or BDNF (Pankratov and Lalo, 2015;Morioka et al, 2021;Liu et al, 2022;Martínez-Gallego et al, 2022). Furthermore, we believe it likely that our findings in acute slices extrapolate to the in vivo situation, based on the findings of Monai and colleagues (Monai et al, 2016).…”
Section: Discussionmentioning
confidence: 86%
“…While the involvement of noradrenergic signaling was not tested in this study (Martínez-Gallego et al, 2022), it clearly adds to the evidence that astrocytes are potent helmsmen of synaptic plasticity direction (Falcón-Moya et al, 2020;Hennes et al, 2020;Wahis et al, 2021b;Koh et al, 2022). Future studies could also explore the molecular mechanisms underlying the role of astrocytes in NA-mediated plasticity in V1, for instance by testing the involvement of potential gliotransmitters, such as ATP/Adenosine, D-Serine, GABA or BDNF (Pankratov and Lalo, 2015;Morioka et al, 2021;Liu et al, 2022;Martínez-Gallego et al, 2022). Furthermore, we believe it likely that our findings in acute slices extrapolate to the in vivo situation, based on the findings of Monai and colleagues (Monai et al, 2016).…”
Section: Discussionmentioning
confidence: 86%